Clinical potential iRepertoire specializes in immune repertoire sequencing with applications in clinical monitoring, minimal residual disease, post-transplant immune monitoring, vaccine studies, and biomarker development, indicating multiple high-value selling opportunities to research labs, hospitals, and biopharma.

Strategic partnerships Existing collaborations with Beckman Coulter and iCubate suggest a proven path for co-development and distribution; leverage these relationships to co-sell integrated workflows, reagents, and automated processing solutions to broaden market reach.

Automation readiness Launch of automated immune repertoire amplification and extraction on the iCubate iC-processor demonstrates scalability and ease-of-use, enabling upsell of turnkey kits and streamlined services to labs seeking higher throughput with reduced hands-on time.

SMB-focused footprint With a small team and revenue in the lower millions, iRepertoire presents an attractive entry point for mid-market institutions and contract research organizations seeking niche sequencing capabilities and affordable access to proprietary analysis tools.

Unique analytics Development of diversity and sharing indices provides disease-specific signatures for diagnosis and prognosis, offering a differentiator for sales pitches around biomarker discovery programs and targeted therapeutic monitoring.